You are currently viewing Further proof Lifewave X39 works – Dr Melinda Conner’s double-blind study.
Lifewave X39 Patch

Further proof Lifewave X39 works – Dr Melinda Conner’s double-blind study.

Dr Melinda Conner proves Lifewave X39 patch works with double blind study.

The recent publication in 2021 of Dr. Melinda Connor’s double-blind study on X39 patches and GHK-Cu production is still sending waves of excitement throughout the whole LifeWave community!

GHK-Cu, also known as Copper Peptide, is a naturally occurring molecule in the body that declines with age. Copper Peptide has been linked to numerous health benefits including activation of stem cells. This highly anticipated study was designed to test the impact of wearing Lifewave X39 patches on the levels of GHK-Cu levels in the blood over the period of one week.

The study collected blood samples from 60 participants in a double-blind placebo-controlled design. Measures were taken at baseline (before patch use), 24 hours after applying the X39 patch, and seven days after wearing X39.

Statistical analysis revealed:

 – Total increase in GHK concentration in ng/ml went from 28.11 on day 2 to 39.09 on day 7.

 – Total GHK-Cu in ng/ml went from 47.43 on day 2 to 66.51 on day 7.

 – This represents about a 40% increase in GHK and GHK-Cu in 1 week when compared to baseline.

In comparison, the subjects that were not wearing active X39 patches experienced no change in GHK or GHK-Cu levels:

 – Day 1 to Day 7 for concentration is 26.83 to 26.36—virtually no change

 – Day 1 to Day 7 for total is 43.2 to 43.23—again, virtually no change

In summary, the study demonstrates that the Lifewave X39 patch elevates GHK and GHK-Cu peptides by about 40% within seven days, as compared to placebo which experiences no changes. These findings support and underscore the experiences X39 users are having all over the world.

This study was performed by esteemed researcher, Dr. Melinda H. Connor. In January of 2020 Dr. Connor was awarded the “Scientist of the Year” at the 20th World Congress on Qigong and was given the honor of receiving recognition by the CA State Legislature for her work. She has also been invited to attend the April 2021 Nobel Prize Summit.

Dr. Connor’s study was published in Internal Medicine Research – Open Journal, an international online journal. It was founded by a group of medical research scientists and clinical scholarly doctors from around the world who are devoted to the promotion and advancement of our understanding of diseases and their treatments.

What an exciting addition to the growing body of scientific research backing LifeWave products! Check out the published, peer-reviewed article here: